Access to new cancer medicines in Australia: dispelling the myths and informing a public debate.

@article{Vitry2016AccessTN,
  title={Access to new cancer medicines in Australia: dispelling the myths and informing a public debate.},
  author={Agnes Isabelle Vitry and Barbara Mintzes and Wendy Lipworth},
  journal={Journal of pharmaceutical policy and practice},
  year={2016},
  volume={9},
  pages={13}
}
Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines-claims that are frequently supported by prominent coverage in the Australian media. These claims, while morally and psychologically compelling, tend to ignore the… CONTINUE READING